Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2.

Decout A, Silva-Gomes S, Drocourt D, Blattes E, Rivière M, Prandi J, Larrouy-Maumus G, Caminade AM, Hamasur B, Källenius G, Kaur D, Dobos KM, Lucas M, Sutcliffe IC, Besra GS, Appelmelk BJ, Gilleron M, Jackson M, Vercellone A, Tiraby G, Nigou J.

Sci Rep. 2018 Nov 15;8(1):16840. doi: 10.1038/s41598-018-35393-5.

2.

Comparing internalization of appearance ideals and appearance-related pressures among women from the United States, Italy, England, and Australia.

Schaefer LM, Burke NL, Anderson LM, Thompson JK, Heinberg LJ, Bardone-Cone AM, Neyland MKH, Frederick DA, Anderson DA, Schaumberg K, Nerini A, Stefanile C, Dittmar H, Klump KL, Vercellone AC, Paxton SJ.

Eat Weight Disord. 2018 Jul 17. doi: 10.1007/s40519-018-0544-8. [Epub ahead of print]

PMID:
30019258
3.

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids.

Blanc L, Gilleron M, Prandi J, Song OR, Jang MS, Gicquel B, Drocourt D, Neyrolles O, Brodin P, Tiraby G, Vercellone A, Nigou J.

Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11205-11210. doi: 10.1073/pnas.1707840114. Epub 2017 Oct 2.

4.

Mass spectrometry analysis of intact Francisella bacteria identifies lipid A structure remodeling in response to acidic pH stress.

Robert CB, Thomson M, Vercellone A, Gardner F, Ernst RK, Larrouy-Maumus G, Nigou J.

Biochimie. 2017 Oct;141:16-20. doi: 10.1016/j.biochi.2017.08.008. Epub 2017 Aug 12.

PMID:
28807561
5.

Rational design of adjuvants targeting the C-type lectin Mincle.

Decout A, Silva-Gomes S, Drocourt D, Barbe S, André I, Cueto FJ, Lioux T, Sancho D, Pérouzel E, Vercellone A, Prandi J, Gilleron M, Tiraby G, Nigou J.

Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2675-2680. doi: 10.1073/pnas.1612421114. Epub 2017 Feb 21.

6.

Education, progressive muscle relaxation therapy, and exercise for the treatment of night eating syndrome. A pilot study.

Vander Wal JS, Maraldo TM, Vercellone AC, Gagne DA.

Appetite. 2015 Jun;89:136-44. doi: 10.1016/j.appet.2015.01.024. Epub 2015 Feb 4.

PMID:
25660340
7.

Impact Laws And Decrees On Activities: The Ilda Study.

Citarella A, De LF, Di MP, Iarrobino A, Nava E, Ragone P, Vercellone A, Cammarota S.

Value Health. 2014 Nov;17(7):A498. doi: 10.1016/j.jval.2014.08.1492. Epub 2014 Oct 26. No abstract available.

8.

Development and validation of the Sociocultural Attitudes Towards Appearance Questionnaire-4 (SATAQ-4).

Schaefer LM, Burke NL, Thompson JK, Dedrick RF, Heinberg LJ, Calogero RM, Bardone-Cone AM, Higgins MK, Frederick DA, Kelly M, Anderson DA, Schaumberg K, Nerini A, Stefanile C, Dittmar H, Clark E, Adams Z, Macwana S, Klump KL, Vercellone AC, Paxton SJ, Swami V.

Psychol Assess. 2015 Mar;27(1):54-67. doi: 10.1037/a0037917. Epub 2014 Oct 6.

PMID:
25285718
9.

Nilotinib for the Frontline Treatment of Chronic Myeloid Leukemia Carrying the p230 Transcript: Dream or Reality?

Capuozzo M, Ottaiano A, Nava E, Cascone S, Cinque C, Vercellone A, Scognamiglio C, Palumbo E, Iaffaioli RV.

Front Oncol. 2014 Feb 3;4:17. doi: 10.3389/fonc.2014.00017. eCollection 2014. Review. No abstract available.

10.

Gram-positive bacterial lipoglycans based on a glycosylated diacylglycerol lipid anchor are microbe-associated molecular patterns recognized by TLR2.

Blanc L, Castanier R, Mishra AK, Ray A, Besra GS, Sutcliffe I, Vercellone A, Nigou J.

PLoS One. 2013 Nov 21;8(11):e81593. doi: 10.1371/journal.pone.0081593. eCollection 2013.

11.

Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization.

Capuozzo M, Ottaiano A, Nava E, Scotti V, Cascone S, Vercellone A, Cinque C, Iaffaioli RV.

Front Pharmacol. 2013 Sep 17;4:114. doi: 10.3389/fphar.2013.00114. eCollection 2013. No abstract available.

12.

Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment.

Blattes E, Vercellone A, Eutamène H, Turrin CO, Théodorou V, Majoral JP, Caminade AM, Prandi J, Nigou J, Puzo G.

Proc Natl Acad Sci U S A. 2013 May 28;110(22):8795-800. doi: 10.1073/pnas.1221708110. Epub 2013 May 13.

13.

Lipoglycans contribute to innate immune detection of mycobacteria.

Krishna S, Ray A, Dubey SK, Larrouy-Maumus G, Chalut C, Castanier R, Noguera A, Gilleron M, Puzo G, Vercellone A, Nampoothiri KM, Nigou J.

PLoS One. 2011;6(12):e28476. doi: 10.1371/journal.pone.0028476. Epub 2011 Dec 2.

14.

Lipoteichoic acid in Streptomyces hygroscopicus: structural model and immunomodulatory activities.

Cot M, Ray A, Gilleron M, Vercellone A, Larrouy-Maumus G, Armau E, Gauthier S, Tiraby G, Puzo G, Nigou J.

PLoS One. 2011;6(10):e26316. doi: 10.1371/journal.pone.0026316. Epub 2011 Oct 18.

15.

Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro.

Meconi S, Vercellone A, Levillain F, Payré B, Al Saati T, Capilla F, Desreumaux P, Darfeuille-Michaud A, Altare F.

Cell Microbiol. 2007 May;9(5):1252-61. Epub 2007 Jan 11.

PMID:
17223928
16.

Acquisition of viral receptor by NK cells through immunological synapse.

Tabiasco J, Vercellone A, Meggetto F, Hudrisier D, Brousset P, Fournié JJ.

J Immunol. 2003 Jun 15;170(12):5993-8.

17.

Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity.

Tabiasco J, Pont F, Fournié JJ, Vercellone A.

Eur J Biochem. 2002 May;269(10):2591-600.

18.

Active trans-synaptic capture of membrane fragments by natural killer cells.

Tabiasco J, Espinosa E, Hudrisier D, Joly E, Fournié JJ, Vercellone A.

Eur J Immunol. 2002 May;32(5):1502-8.

20.

Conventional and non-conventional recognition of non-peptide antigens by T lymphocytes.

Belmant C, Espinosa E, Halary F, Apostolou I, Sicard H, Peyrat MA, Vercellone A, Kourilsky P, Gachelin G, Poupot R, Bonneville M, Fournié JJ.

C R Acad Sci III. 1999 Nov;322(11):919-24. Review. No abstract available.

PMID:
10646084
21.

Mycobacterium tuberculosis H37Rv parietal and cellular lipoarabinomannans. Characterization of the acyl- and glyco-forms.

Gilleron M, Bala L, Brando T, Vercellone A, Puzo G.

J Biol Chem. 2000 Jan 7;275(1):677-84.

22.

Structural definition of arabinomannans from Mycobacterium bovis BCG.

Nigou J, Gilleron M, Brando T, Vercellone A, Puzo G.

Glycoconj J. 1999 Jun;16(6):257-64.

PMID:
10579694
23.
24.

Comparative structural study of the mannosylated-lipoarabinomannans from Mycobacterium bovis BCG vaccine strains: characterization and localization of succinates.

Delmas C, Gilleron M, Brando T, Vercellone A, Gheorghui M, Rivière M, Puzo G.

Glycobiology. 1997 Sep;7(6):811-7.

PMID:
9376683
25.

The costs of dialysis in Italy.

Piccoli G, Formica M, Mangiarotti G, Pacitti A, Piccoli GB, Bajardi P, Cavagnino A, Ghezzi P, Ragni R, Ramello A, Verzetti G, Cesano G, Quarello F, Vercellone A.

Nephrol Dial Transplant. 1997;12 Suppl 1:33-44. Review. No abstract available.

PMID:
9075227
26.

Cytometric detection of mycobacterial surface antigens: exposure of mannosyl epitopes and of the arabinan segment of arabinomannans.

Ozanne V, Ortalo-Magne A, Vercellone A, Fournie JJ, Daffe M.

J Bacteriol. 1996 Dec;178(24):7254-9.

27.

Complete NMR structural elucidation of the capsular polysaccharide adjuvant from Klebsiella I-714.

Adam O, Riviére M, Vercellone A, Monsan PF, Puzo G.

Eur J Biochem. 1996 Oct 15;241(2):602-10.

28.

Incidence of biopsy-proven primary glomerulonephritis in an Italian province.

Stratta P, Segoloni GP, Canavese C, Sandri L, Mazzucco G, Roccatello D, Manganaro M, Vercellone A.

Am J Kidney Dis. 1996 May;27(5):631-9.

PMID:
8629621
29.

[Diabetes mellitus is currently one of the most frequent causes or associated causes of uremia. Data from the Piedmont registry of dialysis and transplantation (update, December 1993)].

Triolo G, Salomone M, Piccoli GB, Torazza MC, Marciello A, Anania P, Grassi G, Ramello A, Cavagnino G, Ragni R, Piccoli G, Vercellone A.

Minerva Urol Nefrol. 1996 Mar;48(1):31-6. Italian.

PMID:
8848766
30.

Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.

Camussi G, Montrucchio G, Lupia E, De Martino A, Perona L, Arese M, Vercellone A, Toniolo A, Bussolino F.

J Immunol. 1995 Jun 15;154(12):6492-501.

PMID:
7539022
31.

A nondegradative route for the removal of endotoxin from exopolysaccharides.

Adam O, Vercellone A, Paul F, Monsan PF, Puzo G.

Anal Biochem. 1995 Mar 1;225(2):321-7.

PMID:
7762798
32.

Are serum albumin and cholesterol reliable outcome markers in elderly dialysis patients?

Piccoli GB, Quarello F, Salomone M, Iadarola GM, Funaro L, Marciello A, Fidelio T, Ghezzi PM, Cavalli PL, Vercellone A, et al.

Nephrol Dial Transplant. 1995;10 Suppl 6:72-7.

PMID:
8524502
33.

Quality of life of renal transplant recipients.

Segoloni GP, Messina M, Squiccimarro G, Tognarelli G, Manzato A, Hamido D, Vercellone A.

Contrib Nephrol. 1994;109:60-4. Review. No abstract available.

PMID:
7956230
34.

Dyslipidemia in renal transplantation: a 3-year follow-up.

Segoloni GP, Triolo G, Cassader M, Turello E, Ruiu G, Messina M, Pagano GF, Vercellone A.

Transplant Proc. 1993 Jun;25(3):2178-9. No abstract available.

PMID:
8516860
35.

Effect of cytokines on the cytoskeleton of resident glomerular cells.

Camussi G, Mariano F, Biancone L, Montrucchio G, Vercellone A.

Kidney Int Suppl. 1993 Jan;39:S32-6. Review.

PMID:
8468923
36.

Immunomodulation and biomaterials.

Tetta C, Camussi G, Mariano F, Triolo G, Vercellone A.

Biomater Artif Cells Immobilization Biotechnol. 1993;21(2):253-63. Review. No abstract available.

PMID:
8318617
37.

Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia.

Stratta P, Canavese C, Dogliani M, Thea A, Degani G, Mairone L, Vercellone A.

Ren Fail. 1993;15(4):559-61.

PMID:
8210571
38.

Specific binding of phenolic glycolipid antigens from Mycobacterium bovis BCG with antibodies.

Vercellone A, Riviere M, Fournié JJ, Puzo G.

FEBS Lett. 1992 May 25;303(1):22-6.

39.

Intravenous cyclophosphamide pulse therapy in the treatment of systemic lupus erythematosus. Long-term results.

Stratta P, Canavese C, Dogliani M, Thea A, Ferrero S, Tognarelli G, Vercellone A.

Contrib Nephrol. 1992;99:126-8. No abstract available.

PMID:
1458918
40.

Clinical implication of antiphospholipid antibodies in systemic lupus erythematosus.

Stratta P, Canavese C, Thea A, Tognarelli G, Dogliani M, Porcu MC, Garis G, Borchiellini A, Schinco PC, Vercellone A.

Contrib Nephrol. 1992;99:123-5. No abstract available.

PMID:
1458917
41.

Impact of donor age in kidney transplantation.

Segoloni GP, Messina M, Triolo G, Cogno C, Amoroso A, Vercellone A.

Transplant Proc. 1991 Oct;23(5):2620-1. No abstract available.

PMID:
1926507
42.

[Role of tumor necrosis factor in hemodiafiltration].

Tetta C, Segoloni G, Fidelio T, Licata C, Sancipriano GP, Iacono G, Ragni R, Vercellone A.

Minerva Urol Nefrol. 1991 Jul-Sep;43(3):181-3. Review. Italian.

PMID:
1817342
43.

The role of free radicals in the progression of renal disease.

Stratta P, Canavese C, Dogliani M, Mazzucco G, Monga G, Vercellone A.

Am J Kidney Dis. 1991 May;17(5 Suppl 1):33-7. Review. No abstract available.

PMID:
2024670
44.

Long-term outcome in patients with vasculitis on chronic dialytic treatment.

Stratta P, Canavese C, Dogliani M, Thea A, Porcu M, Salomone M, Vercellone A.

Contrib Nephrol. 1991;94:151-7. No abstract available.

PMID:
1687274
45.

Immunoglobulin abnormalities in transplant patients: a method for typing monoclonal immunoglobulins.

Segoloni GP, Giacchino F, Rotunno M, Triolo G, Malfi B, Manzione A, Vercellone A.

Transplant Proc. 1990 Aug;22(4):1867-8. No abstract available.

PMID:
2117815
46.

[Long-term results of high-tolerance extracorporeal methods in the light of the new high-efficiency treatments].

Pacitti A, Salomone M, Segoloni GP, Vercellone A.

Minerva Urol Nefrol. 1990 Jan-Mar;42(1):17-22. Italian.

PMID:
2389218
47.

An out-patient approach to sexual problems in uremic patients. An experience in Turin.

Pacitti A, Segoloni GP, Gallone G, Fonzo D, Vercellone A.

Contrib Nephrol. 1990;77:45-55. No abstract available.

PMID:
2344745
48.

Oxygen free radicals in mediating tissue damage: role in nephrological settings.

Stratta P, Canavese C, Gurioli L, Mazzucco G, Monga G, Novara R, Vercellone A.

Contrib Nephrol. 1990;77:132-41. Review. No abstract available.

PMID:
2188782
49.

Production of cytokines in hemodialysis.

Tetta C, Camussi G, Turello E, Salomone M, Aimo G, Priolo G, Segoloni G, Vercellone A.

Blood Purif. 1990;8(6):337-46.

PMID:
2093331
50.

Comparison between two dialytic populations undergoing renal transplantation.

Triolo G, Segoloni GP, Salomone M, Piccoli GB, Messina M, Massara C, Bertinet DB, Vercellone A.

Adv Perit Dial. 1990;6:72-5.

PMID:
1982844

Supplemental Content

Loading ...
Support Center